MOLECULIGHT
Moleculight is developing a non-invasive optical technology that acquires images like standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry-standard wound assessment techniques, including conventional white light visualization. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing a rapid and accurate diagnosis.
MOLECULIGHT
Industry:
Health Care Medical Medical Device
Founded:
2013-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.moleculight.com
Total Employee:
1+
Status:
Active
Contact:
+1 647-362-4684
Email Addresses:
[email protected]
Total Funding:
29.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
No Isolation
We create tailored communication tools to put an end to loneliness.
Quantason
Quantason develops bi-modal US/IDUSâ„¢ platform technology for diagnostic imaging and active screening.
Current Advisors List
Current Employees Featured
Founder
Investors List
BDC Capital Corporation
BDC Capital Corporation investment in Venture Round - MolecuLight
iGan Partners
iGan Partners investment in Venture Round - MolecuLight
SWK Holdings
SWK Holdings investment in Debt Financing - MolecuLight
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - MolecuLight
LVL1 Group
LVL1 Group investment in Convertible Note - MolecuLight
LVL1 Group
LVL1 Group investment in Series B - MolecuLight
iGan Partners
iGan Partners investment in Seed Round - MolecuLight
Official Site Inspections
http://www.moleculight.com Semrush global rank: 4.5 M Semrush visits lastest month: 2.39 K
- Host name: ec2-52-202-167-43.compute-1.amazonaws.com
- IP address: 52.202.167.43
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "MolecuLight" on Search Engine
MolecuLight - Crunchbase Company Profile & Funding
Organization. MolecuLight. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. About. MolecuLight develops portable handheld …See details»
MolecuLight | LinkedIn
MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple …See details»
MolecuLight Company Profile - Craft
MolecuLight has 5 employees across 2 locations and $4 m in total funding,. See insights on MolecuLight including office locations, competitors, revenue, financials, executives, …See details»
MolecuLight i:X Device | The Advanced Wound Care …
Find out how to make a difference in wound care. The MolecuLight i:X is a first-of-its-kind advanced wound care device that allows clinicians to conduct wound imaging and measurement at the point of care.See details»
MolecuLight Featured in 10 Presentations and Posters …
Nov 10, 2022 TORONTO and SALT LAKE CITY, Utah, Nov. 10, 2022 /PRNewswire/ - MolecuLight Inc ., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds,...See details»
MolecuLight announces Health Canada Approval for the
Oct 20, 2015 Founded in 2012, and based in Toronto, Canada, MolecuLight Inc. is a privately-owned medical imaging company delivering fluorescence image-guidance …See details»
MolecuLight - Funding, Financials, Valuation & Investors
MolecuLight has raised a total of. $29.2M. in funding over 6 rounds. Their latest funding was raised on Aug 11, 2022 from a Venture - Series Unknown round. MolecuLight is …See details»
MolecuLight Successfully Completes SOC 2® Type l Audit and
Apr 19, 2023 MolecuLight Inc. is a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform …See details»
MolecuLight Successfully Completes SOC 2 Type II Audit
TORONTO, Dec. 12, 2023 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial loads in and around …See details»
Whitepaper 2020 - Book a Demo Page - MolecuLight
Efficient detection of bacteria means better patient care and improved outcomes. Download the full whitepaper to learn how MolecuLight’s point-of-care bacterial imaging …See details»
MolecuLight Successfully Completes SOC 2 Type II Audit
TORONTO, ON – (December 12, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial loads in and around …See details»
MolecuLight DX Device - MolecuLight US
The MolecuLight® i:X and MolecuLightDXâ„¢ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union. The …See details»
PM 2021 - Reimbursement Info - moleculight.com
View details on the Reimbursement Pathway for the MolecuLight procedure, as well as CME Resources, Training & Education support and Clinical Research.See details»
FAQ - MolecuLight US
The MolecuLight i:X device is straight-forward to learn and operate. The device’s user interface is designed to be intuitive and easy to use, without requiring a technical …See details»
Frequently Asked Questions (FAQ) - MolecuLight
See frequently asked question about MolecuLight Inc. and the MolecuLight iX advanced wound care device.See details»
Webinar 2020 Book a Demo Page - moleculight.com
Learn how MolecuLight’s diagnostic wound imaging system can revolutionize your wound care practice by booking a virtual or live in-clinic demonstration.See details»
User Documentation - MolecuLight US
User Documentation. MolecuLight recommends clinicians review all support materials provided about the MolecuLight i:X (available in 10 languages). Several documents are …See details»